Global Future Challenges Blog

Brain-boosting drugs - just another headache for policymakers?

Posted on: 23 May 2008 in Publications

A report by the Academy of Medical Sciences looking at different aspects of drug use and mental health has identified a growing trend for off-label use of drugs intended for the treatment of diseases including narcolepsy, ADHD and Alzheimer's. The use of such drugs by a healthy individual can improve memory, alertness and concentration. While the report does not condemn the practice, it raises a number of potential concerns over safety, and fairness. Professor Les Iversen, report co-author, highlighted concerns that the use of enhancement in exams would unfairly advantage wealthier students, and suggested that the use of such drugs could be considered cheating. The report recommends that legislation is prepared to tackle the misuse of such drugs, including the potential for urine testing in schools and universities.

Four responses by Oxford academics are posted below. You may continue the discussion by adding your own. Click the "Add comment" link. (Your email address will not be shown on the website.)

These comments are cross-posted on the Practical Ethics blog: Practical Ethics